HC Wainwright & Co. Maintains Buy on Disc Medicine, Raises Price Target to $120
HC Wainwright & Co. analyst Douglas Tsao maintains Disc Medicine (NASDAQ:IRON) with a Buy and raises the price target from $118 to $120.
Read original at benzingaStocks · News reference
Morgan Stanley Maintains Overweight on Disc Medicine, Raises Price Target to $85
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jun 16, 2026, 1:28 PM
- Checked
- Jun 16, 2026, 1:35 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
Disc Medicine Q2 EPS $(1.54) Beats $(1.77) Estimate
Read original at benzinga8-K filing — Disc Medicine, Inc. (IRON)
Filed: 2026-07-30 AccNo: 0001193125-26-325031 Size: 1 MB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Read original at edgar